Avanza Fonder’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$411K Sell
3,267
-9,207
-74% -$1.16M 0.01% 372
2025
Q1
$1.35M Sell
12,474
-744
-6% -$80.6K 0.04% 311
2024
Q4
$1.8M Buy
+13,218
New +$1.8M 0.05% 267